| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |